Despite the remarkable success of immune checkpoint inhibitors (ICIs) in melanoma
treatment, resistance to them remains a substantial clinical challenge. Myeloid-derived …

Adoptive cell therapy with tumor-infiltrating lymphocytes (TIL) is gaining momentum and
demonstrating durable responses in patients with advanced melanoma. Although …

Tumor immunotherapy has emerged as one of the most promising therapeutic methods to
treat cancer. Despite its clinical application, the immunosuppressive tumor …

Advancements in micro‐resolution 3D printers have significantly facilitated the development
of highly complex mass‐producible drug delivery platforms. Conventionally, due to the …

Melanoma represents the most fatal form of skin cancer due to its resistance mechanisms
and high capacity for the development of metastases. Among other medicinal techniques …

Melanoma, a highly heterogeneous tumor, is comprised of a functionally diverse spectrum of
cell phenotypes and subpopulations, including stromal cells in the tumor microenvironment …

Malignant melanoma is one of the most common tumours and has the highest mortality rate
of all types of skin cancers worldwide. Traditional and novel therapeutic approaches …

Melanoma is a highly aggressive form of skin cancer with limited therapeutic options.
Chemo-photothermal combination therapy has demonstrated potential for effectively treating …

Melanoma is the most lethal type of skin cancer, originating from the malignant
transformation of melanocyte. While the development of targeted therapy and …

Although great progress has been made recently in targeted and immune-based therapies,
additional treatments are needed for most melanoma patients due to acquired …